$2.47 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 109 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TRXC | Exit | TRANSENTERIX INC | $0 | – | -61,819 | -100.0% | -0.01% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -1,575 | -100.0% | -0.01% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -10,000 | -100.0% | -0.02% | – |
| SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -55,000 | -100.0% | -0.02% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -8,000 | -100.0% | -0.02% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -50,349 | -100.0% | -0.03% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -32,970 | -100.0% | -0.03% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -27,602 | -100.0% | -0.04% | – |
| KND | Exit | KINDRED HEALTHCARE INC | $0 | – | -72,100 | -100.0% | -0.04% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -166,666 | -100.0% | -0.05% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -279,204 | -100.0% | -0.06% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -5,500 | -100.0% | -0.06% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -65,000 | -100.0% | -0.07% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -11,000 | -100.0% | -0.08% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -18,500 | -100.0% | -0.08% | – |
| MZOR | Exit | MAZOR ROBOTICS LTDsponsored ads | $0 | – | -228,909 | -100.0% | -0.10% | – |
| DSCO | Exit | DISCOVERY LABORATORIES INC N | $0 | – | -8,537,995 | -100.0% | -0.10% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -222,215 | -100.0% | -0.10% | – |
| BITI | Exit | BIOTIE THERAPIES OYJsponsored adr | $0 | – | -219,558 | -100.0% | -0.11% | – |
| PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -209,398 | -100.0% | -0.12% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -110,049 | -100.0% | -0.15% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -700,000 | -100.0% | -0.15% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -100,000 | -100.0% | -0.16% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -160,667 | -100.0% | -0.18% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -461,530 | -100.0% | -0.18% | – |
| DSCI | Exit | DERMA SCIENCES INC | $0 | – | -1,002,201 | -100.0% | -0.18% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -484,664 | -100.0% | -0.24% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -1,040,000 | -100.0% | -0.28% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -4,640,877 | -100.0% | -0.34% | – |
| OFIX | Exit | ORTHOFIX INTL N V | $0 | – | -360,459 | -100.0% | -0.47% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -557,000 | -100.0% | -0.50% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -265,272 | -100.0% | -0.50% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -420,063 | -100.0% | -0.52% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -97,119 | -100.0% | -0.53% | – |
| ELOS | Exit | SYNERON MEDICAL LTD | $0 | – | -2,079,013 | -100.0% | -0.58% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -317,931 | -100.0% | -0.79% | – |
| Exit | WEBMD HEALTH CORPnote 1.500%12/0 | $0 | – | -23,000,000 | -100.0% | -0.91% | – | |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -2,347,113 | -100.0% | -1.11% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -483,000 | -100.0% | -1.60% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.